Iain Mattaj becomes first Director of Human Technople.
18 June 2018 – The Supervisory Board of Human technopole Foundation, during its first meeting, nominates Iain Mattaj Director of Human Technopole.
Since 2005, professor Iain Mattaj is the Director General of the European Molecular Biology Laboratory (EMBL), an intergovernmental organization based in Heidelberg. EMBL is the European flagship laboratory for the life sciences, world-renowned for its outstanding research in molecular biology and for hosting a significant number of Nobel Prize winners over the last twenty years, including the Nobel Prize in Chemistry in 2017 for the cryo-EM.
Born in 1952 in St. Andrews, Scotland, after obtaining the undergraduate degree with honour in Biochemistry at the University of Edinburgh, Iain Mattaj got his PhD from the University of Leeds, UK. He carried out his postdoctoral research at the Friedrich Miescher Institute (CH) and then at the Biocentre, University of Basel. In 1985, Iain Mattaj joined EMBL as Group Leader at the Heidelberg Laboratory. In 1990, he became Coordinator of the Gene Expression Unit, later Scientific Director (1999) and finally he was appointed Director General in 2005.
His research over the years gave relevant contributions in the field of ribonucleoprotein (RNP) particles that function in the processing of messenger RNA precursors. More recently, Mattaj demonstrated the critical role of the Ran GPTase enzyme in the regulation of mitotic events.
Thanks to these important results, Iain Mattaj received many awards such as the Louis-Jeantet for Medicine Prize in 2001, and this year he was elected NAS foreign associate.
Professor Iain Mattaj is the favoured candidate selected by an international and independent committee chaired by the Nobel prize for chemistry Martin Chalfie. The selection procedure started in April 2017, with the international competition announcement for the director position. 46 candidatures has been submitted, half of which from foreigners and the 80% from candidates working abroad. On February 2018 the Coordination Committee ratifies the evaluation of the international committee, approving their job and confirming Iain Mattaj best candidate for the position. On June 18, the Supervisory broad officially nominates Iain Mattaj Director of Human Technopole.
Committed to the development of research and science, and looking for new challenges of high-impact on the scientific community in Europe, Iain Mattaj was attracted by the very ambitious and exciting Human Technopole project. He firmly believes Human Technopole is a great opportunity for developing science in Italy and Europe and to attract top scientists and create a multicultural, multidisciplinary and collaborative ecosystem.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.